Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
After a tough 2022, Cathie Wood's investment in innovation paid off last year. The superstar investor's flagship Ark Innovation soared 67%, well surpassing the gains of the S&P 500 index. This is great, but Wood counts on taking her bets many steps further -- she expects stocks in Ark Innovation and her other funds to advance over the long term.
That's why Wood snapped up more shares of CRISPR Therapeutics (NASDAQ: CRSP), Recursion Pharmaceuticals (NASDAQ: RXRX), and Toast (NYSE: TOST) -- at bargain prices -- this week. Let's take a closer look at these top picks.
Image source: Getty Images.
Source Fool.com